 |
PDBsum entry 1rhf
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Crystal structure of human tyro3-d1d2
|
|
Structure:
|
 |
Tyrosine-protein kinase receptor tyro3. Chain: a, b. Fragment: n-terminal ig-domain. Synonym: tyrosine-protein kinase rse, tyrosine-protein kinase sky, tyrosine-protein kinase dtk, protein-tyrosine kinase byk. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: tyro3, rse, sky, dtk, byk. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
1.96Å
|
R-factor:
|
0.213
|
R-free:
|
0.256
|
|
|
Authors:
|
 |
C.Heiring,B.Dahlback,Y.A.Muller
|
Key ref:
|
 |
C.Heiring
et al.
(2004).
Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl/Tyro3 receptor tyrosine kinase family.
J Biol Chem,
279,
6952-6958.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
14-Nov-03
|
Release date:
|
23-Mar-04
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q06418
(TYRO3_HUMAN) -
Tyrosine-protein kinase receptor TYRO3 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
890 a.a.
176 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.1
- receptor protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
279:6952-6958
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Ligand recognition and homophilic interactions in Tyro3: structural insights into the Axl/Tyro3 receptor tyrosine kinase family.
|
|
C.Heiring,
B.Dahlbäck,
Y.A.Muller.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The receptor Tyro3 together with Axl and Mer form the Axl/Tyro3 family of
receptor tyrosine kinases. Members of this family play essential roles in
spermatogenesis, immunoregulation, and phagocytosis. Gas6, the product of growth
arrest-specific gene, activates the kinase activity of all three receptors.
Here, we report the first biochemical and structural characterization of a
member of this family, namely of a fragment spanning the two N-terminal Ig
domains of the extracellular part of human Tyro3. Its ligand binding specificity
profile is identical to the activation profile of the native receptor. The
1.95-A crystal structure suggests a common ligand-binding site in this receptor
family located at the interface of the Ig domains and unusually rich in
cis-prolines. Furthermore, both in the crystal and in solution we observed the
ligand-independent dimerization of the receptor fragment. This homophilic
interaction emphasizes previous functional reports, which hinted that in
addition to signal transduction, members of this family of receptors might
participate in cell adhesion.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
FIG. 3. Structural details in the Tyro3-D1D2 monomer. A,
stereoview of the interface between the first and second Ig
domains of Tyro3-D1D2. Hydrogen bonds are displayed as yellow
dots. The linker segment is shown in an all atom main chain
representation and the remaining parts as C sketches. The high
number of interactions across the interface suggests a rigid
orientation of the domains. B, stereoview of the
cis-proline-rich BC and C'E loops of the second Ig domain.
|
 |
Figure 4.
FIG. 4. Dimer structure and interface of Tyro3-D1D2. A, the
surface representation of the Tyro3-D1D2 dimer (monomers in red
and green) viewed from two different angles shows that
dimerization occurs solely through interactions between the
N-terminal Ig domains (D1). The two monomers are related to each
other by a 2-fold symmetry. B, overview of the dimer interface.
Amino acids involved in the interface are shown as stick
representations in the case of one monomer; in the second
monomer, the corresponding amino acids are shown in a surface
representation and highlighted in dark green when they are part
of the contract surface. C, hydrogen bond network formed between
B-strand residues across the interface.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2004,
279,
6952-6958)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.K.Ghosh,
C.Secreto,
J.Boysen,
T.Sassoon,
T.D.Shanafelt,
D.Mukhopadhyay,
and
N.E.Kay
(2011).
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy.
|
| |
Blood,
117,
1928-1937.
|
 |
|
|
|
|
 |
S.Loges,
T.Schmidt,
M.Tjwa,
K.van Geyte,
D.Lievens,
E.Lutgens,
D.Vanhoutte,
D.Borgel,
S.Plaisance,
M.Hoylaerts,
A.Luttun,
M.Dewerchin,
B.Jonckx,
and
P.Carmeliet
(2010).
Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6.
|
| |
Blood,
115,
2264-2273.
|
 |
|
|
|
|
 |
J.G.Weinger,
K.M.Omari,
K.Marsden,
C.S.Raine,
and
B.Shafit-Zagardo
(2009).
Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions.
|
| |
Am J Pathol,
175,
283-293.
|
 |
|
|
|
|
 |
A.Angelillo-Scherrer,
L.Burnier,
D.Lambrechts,
R.J.Fish,
M.Tjwa,
S.Plaisance,
R.Sugamele,
M.DeMol,
E.Martinez-Soria,
P.H.Maxwell,
G.Lemke,
S.P.Goff,
G.K.Matsushima,
H.S.Earp,
M.Chanson,
D.Collen,
S.Izui,
M.Schapira,
E.M.Conway,
and
P.Carmeliet
(2008).
Role of Gas6 in erythropoiesis and anemia in mice.
|
| |
J Clin Invest,
118,
583-596.
|
 |
|
|
|
|
 |
J.G.Weinger,
P.Gohari,
Y.Yan,
J.M.Backer,
B.Varnum,
and
B.Shafit-Zagardo
(2008).
In brain, Axl recruits Grb2 and the p85 regulatory subunit of PI3 kinase; in vitro mutagenesis defines the requisite binding sites for downstream Akt activation.
|
| |
J Neurochem,
106,
134-146.
|
 |
|
|
|
|
 |
M.Tjwa,
L.Bellido-Martin,
Y.Lin,
E.Lutgens,
S.Plaisance,
F.Bono,
N.Delesque-Touchard,
C.Hervé,
R.Moura,
A.D.Billiau,
C.Aparicio,
M.Levi,
M.Daemen,
M.Dewerchin,
F.Lupu,
J.Arnout,
J.M.Herbert,
M.Waer,
P.García de Frutos,
B.Dahlbäck,
P.Carmeliet,
M.F.Hoylaerts,
and
L.Moons
(2008).
Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes.
|
| |
Blood,
111,
4096-4105.
|
 |
|
|
|
|
 |
I.C.Viorritto,
N.P.Nikolov,
and
R.M.Siegel
(2007).
Autoimmunity versus tolerance: can dying cells tip the balance?
|
| |
Clin Immunol,
122,
125-134.
|
 |
|
|
|
|
 |
S.Hafizi,
and
B.Dahlbäck
(2006).
Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily.
|
| |
FEBS J,
273,
5231-5244.
|
 |
|
|
|
|
 |
T.Sasaki,
P.G.Knyazev,
N.J.Clout,
Y.Cheburkin,
W.Göhring,
A.Ullrich,
R.Timpl,
and
E.Hohenester
(2006).
Structural basis for Gas6-Axl signalling.
|
| |
EMBO J,
25,
80-87.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Angelillo-Scherrer,
L.Burnier,
N.Flores,
P.Savi,
M.DeMol,
P.Schaeffer,
J.M.Herbert,
G.Lemke,
S.P.Goff,
G.K.Matsushima,
H.S.Earp,
C.Vesin,
M.F.Hoylaerts,
S.Plaisance,
D.Collen,
E.M.Conway,
B.Wehrle-Haller,
and
P.Carmeliet
(2005).
Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy.
|
| |
J Clin Invest,
115,
237-246.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |